37 results on '"Lahat, Adi"'
Search Results
2. CURCUMIN-QINGDAI COMBINATION FOR PATIENTS WITH ACTIVE ULCERATIVE COLITIS: A RANDOMIZED DOUBLE-BLINDED PLACEBO-CONTROLLED CLINICAL TRIAL
3. 901 CAPSULE ENDOSCOPY-GUIDED PROACTIVE TREATMENT VERSUS STANDARD CARE IN PATIENTS WITH QUIESCENT CROHN'S DISEASE: THE CURE-CD RANDOMIZED CONTROLLED TRIAL
4. Tu1754 MODELS FOR PREDICTING CROHN DISEASE (CD) EXACERBATION USING SERUM AND FECAL METABOLOMICS
5. Mo1771 INTESTINAL ULTRASOUND MEASURES ARE HIGHLY CORRELATED WITH SMALL BOWEL LEWIS SCORE AMONG PATIENTS WITH ACTIVE CROHN'S DISEASE
6. Mo1350 BOTANICAL COMBINATION OF CURCUMIN AND COPTIS CHINESE FOR THE TREATMENT OF POST-DIVERTICULITS SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE: RESULTS OF A PHASE 1B STUDY
7. Su1762 SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) AS MAINTENANCE THERAPY FOR CROHN'S DISEASE: 2 YEARS RESULTS OF THE LIBERTY-CD STUDY
8. INCIDENTALLY DIAGNOSED ASYMPTOMATIC CROHN'S DISEASE: LONG-TERM CLINICAL OUTCOMES OF UNTREATED PATIENTS
9. Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease
10. Fr511 IMMUNE FUNCTION IN NEWBORNS OF FEMALES WITH GESTATIONAL ANTI- TNFα MEDICATION THERAPY FOR INFLAMMATORY BOWEL DISEASE
11. Mo1720 UNTARGETED SERUM METABOLOME SHOWS CROHN DISEASE (CD) ASSOCIATED SIGNATURE, SIGNALS THAT CORRELATE WITH DISEASE ACTIVITY AND CRP, AND SIGNALS THAT MAY PRECEDE DISEASE FLARE
12. Sa1861 CROHN DISEASE UNTARGETED FECAL METABOLOME SHOWS STRONG CORRELATION WITH SPECIFIC SALIVARY ASSOCIATED MICROBIAL TAXA, AND WITH DISEASE ACTIVITY
13. 1028 SUBCUTANEOUS INFLIXIMAB (CT-P13) AS MAINTENANCE THERAPY FOR CROHN'S DISEASE: A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDY (LIBERTY-CD).
14. 289 UNSEDATED COLONOSCOPY UTILIZING VIRTUAL REALITY DISTRACTION – A PILOT CONTROLLED STUDY
15. QINGDAI (QD) FOR PATIENTS WITH ACTIVE ULCERATIVE COLITIS: A RETROSPECTIVE ISRAELI NATIONAL EXPERIENCE
16. 948 A NOVEL SUBCUTANEOUS INFLIXIMAB (CT-P13) IN PATIENTS WITH ACTIVE CROHN'S DISEASE AND ULCERATIVE COLITIS: WEEK54 AND SWITCHING RESULTS FROM A MULTICENTER, RANDOMISED CONTROLLED PIVOTAL TRIAL
17. Tu1877 EVALUATION OF CLINICAL RELATIONSHIP BETWEEN FECAL CALPROTECTIN AND ENDOSCOPIC RESULT IN ULCERATIVE COLITIS PATIENTS TREATED WITH INFILXIMAB SUBCUTANEOUS AND INTRAVENOUS THERAPY: RESULTS FROM A MULTICENTER, RANDOMIZED, CONTROLLED PIVOTAL TRIAL
18. Tu1715 – A Novel Formulation of Ct-P13 (Infliximab Biosimilar) for Subcutaneous Administration: 1-Year Result from a Phase I Open-Label Randomized Controlled Trial in Patients with Active Crohn's Disease
19. 1150 – Intra-Personal Gut Microbial Variations in Patients with Quiescent Crohn Disease Predict Subsequent Disease Flare
20. Mo1887 - Safety, Efficacy and Pharmacokinetics of Vedolizumab in Patients with Simultaneous Exposure to an Anti-TNF
21. 814 - Phase Iii Randomized Controlled Trial to Compare Biosimilar Infliximab (CT-P13) with Innovator Infliximab in Patients with Active Crohn's Disease: 1-Year Maintenance and Switching Results
22. 347 - Impact of Drug Levels, Anti-Drug Antibodies and α4β7 Target Occupnacy on the Response to Vedolizumab Therapy in Patients with Inflmmatory Bowel Disease
23. Tu2018 - Novel Formulation of CT-P13 (Infliximab Biosimilar) for Subcutaneous Administration: Initial Results from a Phase I Open-Label Randomized Controlled Trial in Patients with Active Crohn's Disease
24. 599 - Comprhensive Video Capsule Endosocpy-Based Monitoring Predicts Short and Long-Term Risk of Disease Flares in Small Bowel Crohn's Disease: A Prospective Cohort Study
25. Su1178 - Serum MMP-9 - A Novel Biomarker for Prediction of Clinical Relapse in Patients with Quiescent small Bowel Crohn's Disease
26. Su1899 - Vedolizumab is Safe for use in Pregnant Patients with IBD; Report of Our Preliminary Data
27. Elevated Clinical Inflammatory Markers and Cytokine Expression in Peri- Diverticular Colonic Tissue in Patients Post Complicated Versus Uncomplicated Acute Diverticulitis
28. Phase III Randomized, Double-Blind, Controlled Trial to Compare Biosimilar Infliximab (CT-P13) with Innovator Infliximab (INX) in Patients with Active Crohn's Disease: Early Efficacy and Safety Results
29. Tu1954 Capsule Endoscopy Findings and Fecal Calprotectin Levels Predict Clinical Relapse in Patients With Quiescent Small Bowel Crohn's Disease
30. Accuracy of Capsule Colonoscopy in Detecting Colorectal Polyps in a Screening Population
31. Su1224 Small Bowel Mucosal Healing and Deep Remission in Patients With Known Small Bowel Crohn's Disease
32. Sa1174 The Impact of Magnetic Resonance Enterography and Capsule Endoscopy on the Classification of Disease in Patients With Known Crohn's Disease: A Prospective Israeli IBD Research Network (IIRN) Study
33. 324 Quantification of Inflammation in Small Bowel Crohn's Disease Patients by Videocapsule Endoscopy and Magnetic Resonance Enterography
34. Mo1896 - Elevated Clinical Inflammatory Markers and Cytokine Expression in Peri- Diverticular Colonic Tissue in Patients Post Complicated Versus Uncomplicated Acute Diverticulitis
35. Mo1211 Oral Administration of Non-Absorbable Delayed Release 6-Mercaptopurine is Locally Active in the Gut, Exerts a Systemic Immune Effect and Alleviates Crohn's Disease With Low Rate of Side Effects: Results of Double Blind Phase II Clinical Trial
36. Diverticulitis in the Young: Is It Indeed More Aggressive and Tends to Recur? – Systematic Review and Meta-Analysis
37. The Traveling IBD Patient – A Case-Controlled Study of Travel-Associated Health Risks
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.